Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension

Uricase catalyzes the conversion of uric acid into allantoin with concomitant reduction of molecular oxygen to hydrogen peroxide. In humans, uricase is not functional, thereby predisposing individuals to hyperuricemia, a metabolic disturbance associated with gout, chronic kidney disorders, and cardi...

Full description

Bibliographic Details
Main Authors: Benoit Pugin, Serafina Plüss, Denisa Mujezinovic, Rikke C. Nielsen, Christophe Lacroix
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.853735/full
_version_ 1818015306668310528
author Benoit Pugin
Serafina Plüss
Denisa Mujezinovic
Rikke C. Nielsen
Christophe Lacroix
author_facet Benoit Pugin
Serafina Plüss
Denisa Mujezinovic
Rikke C. Nielsen
Christophe Lacroix
author_sort Benoit Pugin
collection DOAJ
description Uricase catalyzes the conversion of uric acid into allantoin with concomitant reduction of molecular oxygen to hydrogen peroxide. In humans, uricase is not functional, thereby predisposing individuals to hyperuricemia, a metabolic disturbance associated with gout, chronic kidney disorders, and cardiovascular diseases. The efficacy of current therapies to treat hyperuricemia is limited, and novel approaches are therefore desired, for instance using uricase-expressing probiotic strains. Here, we evaluated UV-spectrophotometric and H2O2-based fluorescent assays to enable the rapid identification of uricase activity in a broad panel of lactobacilli, Bacillus, and Bifidobacterium species. We highlighted abiotic (medium composition and mode of sterilization) and biotic (H2O2-producing strains) factors impacting the measurements’ accuracy, and reported on the stepwise optimization of a simple, fast, and robust high-throughput UV-spectrophotometric method to screen uricase activity using whole bacterial suspension, thereby assessing both cell-associated and extracellular activity. The validity of the optimized assay, based on the monitoring of uric acid degradation at 300 nm, was confirmed via liquid chromatography. Finally, a panel of 319 Qualified Presumption of Safety (QPS) strains of lactobacilli (18 species covering nine genera), Bacillus (three species), and Bifidobacterium (four species) were screened for uricase activity using the optimized method. All 319 strains, but the positive control Bacillus sp. DSM 1306, were uricase-negative, indicating that this activity is rare among these genera, especially in isolates from food or feces. Altogether, the UV-spectrophotometric high-throughput assay based on whole bacterial suspension reported here can be used to rapidly screen large microbial collections, by simultaneously detecting cell-associated and extracellular uricase activity, thereby accelerating the identification of uricolytic strains with therapeutic potential to treat hyperuricemia.
first_indexed 2024-04-14T06:55:21Z
format Article
id doaj.art-8408253847134015b21ab6de506cdfbe
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-14T06:55:21Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-8408253847134015b21ab6de506cdfbe2022-12-22T02:06:54ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-04-011310.3389/fmicb.2022.853735853735Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell SuspensionBenoit Pugin0Serafina Plüss1Denisa Mujezinovic2Rikke C. Nielsen3Christophe Lacroix4Laboratory of Food Biotechnology, Department of Health Sciences and Technology, ETH Zürich, Zürich, SwitzerlandLaboratory of Food Biotechnology, Department of Health Sciences and Technology, ETH Zürich, Zürich, SwitzerlandLaboratory of Food Biotechnology, Department of Health Sciences and Technology, ETH Zürich, Zürich, SwitzerlandBeo Therapeutics AG, Zürich, SwitzerlandLaboratory of Food Biotechnology, Department of Health Sciences and Technology, ETH Zürich, Zürich, SwitzerlandUricase catalyzes the conversion of uric acid into allantoin with concomitant reduction of molecular oxygen to hydrogen peroxide. In humans, uricase is not functional, thereby predisposing individuals to hyperuricemia, a metabolic disturbance associated with gout, chronic kidney disorders, and cardiovascular diseases. The efficacy of current therapies to treat hyperuricemia is limited, and novel approaches are therefore desired, for instance using uricase-expressing probiotic strains. Here, we evaluated UV-spectrophotometric and H2O2-based fluorescent assays to enable the rapid identification of uricase activity in a broad panel of lactobacilli, Bacillus, and Bifidobacterium species. We highlighted abiotic (medium composition and mode of sterilization) and biotic (H2O2-producing strains) factors impacting the measurements’ accuracy, and reported on the stepwise optimization of a simple, fast, and robust high-throughput UV-spectrophotometric method to screen uricase activity using whole bacterial suspension, thereby assessing both cell-associated and extracellular activity. The validity of the optimized assay, based on the monitoring of uric acid degradation at 300 nm, was confirmed via liquid chromatography. Finally, a panel of 319 Qualified Presumption of Safety (QPS) strains of lactobacilli (18 species covering nine genera), Bacillus (three species), and Bifidobacterium (four species) were screened for uricase activity using the optimized method. All 319 strains, but the positive control Bacillus sp. DSM 1306, were uricase-negative, indicating that this activity is rare among these genera, especially in isolates from food or feces. Altogether, the UV-spectrophotometric high-throughput assay based on whole bacterial suspension reported here can be used to rapidly screen large microbial collections, by simultaneously detecting cell-associated and extracellular uricase activity, thereby accelerating the identification of uricolytic strains with therapeutic potential to treat hyperuricemia.https://www.frontiersin.org/articles/10.3389/fmicb.2022.853735/fulluricasespectrophotometryfluorescencehigh-throughput screeninglactobacilliBacillus
spellingShingle Benoit Pugin
Serafina Plüss
Denisa Mujezinovic
Rikke C. Nielsen
Christophe Lacroix
Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension
Frontiers in Microbiology
uricase
spectrophotometry
fluorescence
high-throughput screening
lactobacilli
Bacillus
title Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension
title_full Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension
title_fullStr Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension
title_full_unstemmed Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension
title_short Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension
title_sort optimized uv spectrophotometric assay to screen bacterial uricase activity using whole cell suspension
topic uricase
spectrophotometry
fluorescence
high-throughput screening
lactobacilli
Bacillus
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.853735/full
work_keys_str_mv AT benoitpugin optimizeduvspectrophotometricassaytoscreenbacterialuricaseactivityusingwholecellsuspension
AT serafinapluss optimizeduvspectrophotometricassaytoscreenbacterialuricaseactivityusingwholecellsuspension
AT denisamujezinovic optimizeduvspectrophotometricassaytoscreenbacterialuricaseactivityusingwholecellsuspension
AT rikkecnielsen optimizeduvspectrophotometricassaytoscreenbacterialuricaseactivityusingwholecellsuspension
AT christophelacroix optimizeduvspectrophotometricassaytoscreenbacterialuricaseactivityusingwholecellsuspension